Treatment of Meningitis Due toHaemophilus influenzae

Abstract

THE treatment of meningitis due to Haemophilus influenzae has undergone considerable change in the past fifteen years. Prior to the advent of specific therapy, this disease was fatal in 90 to 100 per cent of cases, and in the rare cases in which recovery took place, severe neurologic sequelae were frequently encountered. Wilkes-Weiss and Huntington,¹ in a review of the literature in 1936, reported 500 cases in patients of all ages, with a mortality of 92.2 per cent.The introduction of Fothergill's specific antiserum and complement, together with the sulfonamide drugs, represented a considerable advance in the therapy of this . . .